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Abstract
Introduction: Experience with high-frequency oscillatory ventilation (HFOV) after congenital cardiac surgery is
limited despite evidence about reduction in pulmonary vascular resistance after the Fontan procedure. HFOV is
recommended in adults and children with acute respiratory distress syndrome. The aim of the present study was
to assess associations between commencement of HFOV on the day of surgery and length of mechanical
ventilation, length of Intensive Care Unit (ICU) stay and mortality in neonates and infants with respiratory distress
following cardiac surgery.
Methods: A logistic regression model was used to develop a propensity score, which accounted for the
probability of being switched from conventional mechanical ventilation (CMV) to HFOV on the day of surgery. It
included baseline characteristics, type of procedure and postoperative variables, and was used to match each
patient with HFOV with a control patient, in whom CMV was used exclusively. Length of mechanical ventilation,
ICU stay and mortality rates were compared in the matched set.
Results: Overall, 3,549 neonates and infants underwent cardiac surgery from January 2001 through June 2010, 120
patients were switched to HFOV and matched with 120 controls. After adjustment for the delay to sternal closure,
duration of renal replacement therapy, occurrence of pulmonary hypertension and year of surgery, the probability
of successful weaning over time and the probability of ICU delivery over time were significantly higher in patients
with HFOV, adjusted hazard ratios and 95% confidence intervals: 1.63, 1.17 to 2.26 (P = 0.004). and 1.65, 95%
confidence intervals: 1.20 to 2.28 (P = 0.002) respectively. No association was found with mortality.
Conclusions: When commenced on the day of surgery in neonates and infants with respiratory distress following
cardiac surgery, HFOV was associated with shorter lengths of mechanical ventilation and ICU stay than CMV.
Introduction
High-frequency oscillatory ventilation (HFOV) is an
established treatment for acute respiratory distress in
preterm neonates. However, there is no evidence that it
improves outcome in term or near-term neonates with
pulmonary disease [1]. HFOV is considered as a rescue
therapy in children with severe acute respiratory distress
syndrome (ARDS), but to date there is lack of evidence
to support it [2,3]. HFOV is also used to achieve lung
recruitment and improve oxygenation when recruitment
maneuvers have failed, as part of the “open lung” and
lung protective ventilation strategies in adults with
severe ARDS; early initiation of HFOV has been asso-
ciated with improved outcome [4-6]. Mild acute lung
injury occurs in 12% of adults following cardiopulmon-
ary bypass (CPB), and more severe lung injury, indistin-
guishable from ARDS, in 0.4% [7,8], as a result of
accumulation of excessive extrapulmonary lung water,
decreased lung compliance, atelectasis and increased
shunting.
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Experience with HFOV following cardiac surgery is
limited, due to concerns about hemodynamic impair-
ment in animal and human studies [6,9-13]. However,
HFOV has been associated with a significant reduction
in pulmonary vascular resistance (PVR) after the Fontan
procedure in children [14]. Thought to be beneficial for
gas exchange and PVR, the present authors have used
HFOV in neonates and infants with respiratory distress
following cardiac surgery since January 2007. The aim
of the present study was to assess associations between
commencement of HFOV on the day of surgery (Day 0)
and the length of mechanical ventilation and Intensive
Care Unit (ICU) stay, and mortality in this population.
Materials and methods
This retrospective cohort study was conducted at the
Necker University Hospital in Paris, France. It was
reviewed and approved by the Ethics Committee of the
French Society of Thoracic and Cardiovascular Surgery,
which waived the requirement for consent to use anon-
ymized records. All parents had provided informed con-
sent to surgery.
Records of all neonates and infants who underwent
cardiac surgery between 1 January 2001 and 30 June
2010 were reviewed; patients switched to HFOV on Day
0 were identified as the HFOV group. Those switched
to HFOV after Day 0, as a rescue therapy, were not ana-
lyzed. The remaining patients were included in the con-
trol group. Data for each patient were extracted
retrospectively from a prospective database, which is
updated daily by the clinical staff. These concerned:
demographics, surgical and CPB techniques, short-term
outcome variables accounting for the severity of the
postoperative illness, such as re-operation, delayed ster-
nal closure, extracorporeal membrane oxygenation
(ECMO), acute kidney injury requiring renal replace-
ment therapy (RRT), and hospital-acquired pneumonia
[15], length of mechanical ventilation, length of ICU
stay and in-hospital mortality. Normothermic CPB with
intermittent warm blood cardioplegia was performed in
every patient during the study period, except in cases
where deep hypothermic circulatory arrest (DHCA) was
indicated [16]. Pulmonary arterial pressure was mea-
sured in every patient, either continuously by a catheter
inserted into the pulmonary artery by the end of sur-
gery, or by serial echocardiography. Persistent pulmon-
ary hypertension was noted whenever it occurred during
the postoperative course, and inhaled nitric oxide was
administered [17].
All patients were initially commenced on pressure
controlled conventional mechanical ventilation (CMV)
using a SERVO-300 (Siemens-Elema AB, Sweden) before
2002, then a SERVO-i ventilator (Maquet GmbH&Co.
KG, Rastatt, Germany). This was set to provide a
positive end expiratory pressure of 2 cmH2O, a tidal
volume of 6 to 8 ml Kg-1, and a fraction of inspired oxy-
gen, which was dependent upon the underlying cardiac
disease. In the event of severe respiratory failure,
recruitment maneuvers by stepwise increase in the
mean airway pressure were applied. The patients were
switched to HFOV when hypoxemia and acidosis
occurred despite increasing alveolar ventilation on
CMV, when the tidal volume exceeded 10 ml kg-1, or
when there was evidence of pulmonary hypertension
and right ventricular failure. The decision to switch was
made by the attending intensivist. A SLE 2000 or a SLE
5000 HFO ventilator (SLE Ltd, South Croydon, UK) was
used. This was set to a mean airway pressure (Paw) of
12 cmH2O, an inspiratory to expiratory ratio of 33%,
and an oscillation frequency of 8 Hz. Amplitude was
adapted to achieve adequate chest wall vibrations. All
parameters were adjusted to achieve optimal inflation, a
PaCO2 of 35 to 45 mmHg and a pH > 7.35. The ade-
quacy of the PaO2 level was judged according to the
underlying cardiac disease. Patients were switched back
to CMV when these conditions had been achieved with
an oscillation frequency ≥10 Hz and a mean Paw ≤10
cmH2O. Sedation was achieved through a continuous
infusion of midazolam and morphine. Whenever possi-
ble, muscular relaxants were avoided and spontaneous
breathing was maintained. Catecholamine support (mil-
rinone and epinephrine), fluid support and diuretics
were administered as appropriate to achieve hemody-
namic stability and a negative fluid balance. All patients
were weaned from mechanical ventilation when the
underlying indication had resolved and following a suc-
cessful one-hour trial of spontaneous breathing with a
continuous positive pressure of 2 cmH2O and a pressure
support of 10 cmH2O.
Statistical analysis
After testing for normality, baseline characteristics of
the two groups were compared using Student’s t or
Mann-Whitney tests for continuous variables and c2 or
Fisher’s exact tests for categorical variables.
The hypothesis tested was that patients switched to
HFOV had shorter length of mechanical ventilation and
ICU stay and lower mortality rates. To control for the
bias due to selection of patients switched to HFOV, 1:1
propensity score matching was carried out [18]. Logistic
regression was used to develop a propensity score quan-
tifying the probability for each patient undergoing sur-
gery since January 2007 to be switched to HFOV. This
included all baseline and post-operative variables
accounting for severity of illness found to be different
between groups in univariate analysis (P < 0.10), and the
“HFOV index”. Given the large number of surgical pro-
cedures and the absence of guidelines for HFOV in this
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context, an empirical “HFOV index” was attributed to
each procedure. This accounted for the influence of
each specific procedure being performed on the prob-
ability to be switched to HFOV afterwards, and was cal-
culated as the prevalence of HFOV per procedure
between January 2007 and June 2010.
In accordance with previous authors, length of
mechanical ventilation and length of ICU stay were
modeled as censored variables in survivors, with wean-
ing from mechanical ventilation and ICU delivery as
censoring events [19]. The probability of successful
weaning from mechanical ventilation over time and the
probability of ICU delivery over time were calculated for
each group using the Kaplan-Meier method, and com-
pared using the log-rank test. Results were confirmed
using a multivariable Cox proportional-hazards model,
controlling for variables related to length of ICU stay
following pediatric cardiac surgery in a previous study
[20], variables unbalanced after matching (P < 0.10), for
the propensity score and the year of surgery. Adjusted
Hazard ratios (HR) with 95% confidence intervals were
estimated.
The R statistical package, “Design” and “optmatch”
libraries [21] were used for the analyses.
Results
Overall, 3,549 neonates and infants underwent cardiac
surgery during the study period. Life support was with-
drawn from four patients with obstructed total anoma-
lous pulmonary venous connection and one patient with
severe pulmonary hypoplasia, with hopeless prognosis
secondary to pulmonary lymphangienctasia. Another
two patients died periprocedural, leaving 3,542 cases to
be analyzed. The number of patients, their length of
mechanical ventilation and ICU stay across the study
period are shown in Figures 1 and 2.
Patient characteristics are shown in Table 1. The 120
neonates and infants switched to HFOV on Day 0 were
younger and smaller, had undergone more complex sur-
gery and had experienced more severe postoperative ill-
ness. Patients switched to HFOV had longer durations
of both mechanical ventilation, median 7 days, inter-
quartile ranges (IQR) 5 to 11 vs. 1 day, IQR 0.3 to 4 in
controls (P < 0.001), and ICU stay, median 11 days, IQR
7 to 15.7 vs. 4 days, IQR 3 to 7 (P < 0.001). The median
duration of HFOV was 4 days, IQR 2 to 7. The in-hos-
pital mortality rates for the two groups were similar,
8.3% in patients switched to HFOV vs. 4.8% in controls
(P = 0.08).
Table 2 shows the most prevalent procedures and
their “HFOV indexes”, range 0 to 0.82, median 0.04,
IQR 0.03 to 0.08. Table 3 shows the variables included
in the propensity score. When data were missing, the
median of the respective variable was used (< 5% of all
information concerning CPB technique was missing).
The propensity score model was well calibrated (Hos-
mer Lemeshow test, P = 0.14) and discriminated well
between patients on HFOV and the others (c index =
0.82). Patients were more likely to be switched to HFOV
on Day 0 if they were small, had undergone a procedure
with high “HFOV index”, required CPB and DHCA, had
hemodynamic impairment precluding closure of the
sternum or required RRT on Day 0. Patients com-
menced on postoperative ECMO were not matched due
to their high mortality rate (39.1%).
Matching resulted in two well-balanced groups of 120
patients respectively: the HFOV and the CMV groups
(Table 1). The HFOV group had shorter durations of
mechanical ventilation, 7 days, IQR 5 to 11 vs 9 days,
IQR 5 to 17 in the CMV group (P = 0.03), shorter dura-
tions of ICU stay, 11 days, IQR 5 to 17 vs 14 days, IQR
9 to 22 (P = 0.009), a higher prevalence of pulmonary
hypertension, 36.7%, compared to 23.3% (P = 0.03) and
a similar prevalence of hospital-acquired pneumonia,
49.2% in the HFOV group compared to 47.5% in the
CMV group (P = 0.80). Ten patients in the HFOV
group (8.3%) died during ICU stay, compared to 18 in
the CMV group (15.8%) (P = 0.08). Median follow-up
was 411 days, IQR 32 to 3,060, 18 patients (15.8%) died
during follow-up in the HFOV group, compared to 22
in the CMV group (18.3%) (P = 0.66).
Kaplan-Meier plots of the probability of successful
weaning from mechanical ventilation over time are shown
in Figure 3. The median length of mechanical ventilation
was 7 days in the HFOV group, IQR 5 to 11, and 9 days in
the CMV group, IQR 5 to 17 (P = 0.01). Four patients in
the HFOV group underwent mechanical ventilation for ≥
30 days. Of these, one developed tracheal stenosis and
underwent slide tracheoplasty, another required tracheost-
omy. Ten patients in the CMV group underwent mechani-
cal ventilation for ≥ 30 days. Of these, two developed
tracheal stenosis, one of whom died, one developed oeso-
tracheal fistula and died, and seven developed chronic
lung disease, of whom four required tracheostomy and
two died. Kaplan-Meier plots of the probability of ICU
delivery over time are shown in Figure 4. The median
length of ICU stay was 11 days in the HFOV group, IQR
7.2 to 15.7 and 14 days in the CMV group, IQR 9 to 22 (P
= 0.002). Differences between length of ventilation and
ICU stay were found significant with a statistical power of
0.77 and 0.89, respectively.
Cox proportional-hazards regression analysis, adjusted
for the delay to sternal closure, duration of RRT, occur-
rence of pulmonary hypertension and year of surgery,
showed that patients in the HFOV group had a higher
probability of successful weaning over time, adjusted HR
1.63; 95% confidence interval (CI) 1.17 to 2.23 (P =
0.004) (Table 4). The probability of ICU delivery over
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Figure 1 Number of neonates and infants who underwent surgery during the study period. The number of patients included in each
group after matching is shown on the bottom of each column. High frequency oscillation was used since 2007. CMV, conventional mechanical
ventilation; HFOV, high-frequency oscillatory ventilation.
Figure 2 Length of mechanical ventilation and Intensive Care Unit stay across the study period. The median values and the inter-quartile
ranges were used to construct the boxes. 10th and 90th percentiles are given as whiskers. Outliers are not shown. ICU, Intensive Care Unit.
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time was also higher in the HFOV group, adjusted HR
1.65, 95% CI 1.20 to 2.28 (P = 0.002) (Table 4). Longer
delay to sternal closure was independently associated
with longer length of mechanical ventilation and ICU
stay.
Discussion
The present study reports experience with HFOV in a
population of neonates and infants with respiratory dis-
tress following several cardiac surgery procedures. Pre-
vious findings reported from randomized trials of HFOV
in term or near-term neonates with pulmonary disease
showed no benefit in terms of 28-day mortality [1], and
our findings were similar. But, unlike previous research
on elective use of HFOV, length of mechanical ventila-
tion and length of stay were reduced among patients
with a similar severity of illness when they were
switched to HFOV on the day of surgery.
HFOV and PVR
The most common reasons for late weaning from
mechanical ventilation following congenital cardiac sur-
gery are a low cardiac output state or a respiratory com-
plication. Even when ventricular function is well
preserved and no residual anatomical lesion is present, a
low cardiac output may result from inadequate pulmon-
ary blood flow, secondary to elevated PVR. Maintenance
of cardiac output by fluid challenge, to ensure adequate
preload, leads to extravascular fluid accumulation,
pleural and pericardial effusions, pulmonary interstitial
edema and decreased compliance. The loss of intravas-
cular volume must be replaced to maintain cardiac out-
put, which may initiate a vicious cycle, and should,
therefore, be avoided.
PVR is multifactorial after CPB [22,23] and highly sen-
sitive to changes in intra-thoracic pressure [24] and
acidosis [25]. Changes in intra-thoracic pressure have
been extensively investigated in the Fontan procedure,
where high-frequency ventilation has been found to be
associated with an increase of up to 25% in cardiac out-
put and led to halve PVR and mean Paw [14]. Although
HFOV is known to be effective in settings leading to
hypoxemia, the use has been described in reports of
asthma and severe bronchiolitis to treat respiratory
acidosis [26,27]. According to Babik et al. [23], CPB is
responsible for an obstructive process in the bronchi,
leading to bronchospasm and acidosis. Bronchospasm is
also a frequent postoperative finding in patients with a
Table 1 Perioperative patient characteristics before and after matching











Age (days) 27, 7.7 to 100.2 58, 10 to 149 0.001 33.0, 7.0 to 89.5 0.83
Weight (kg) 3.4, 2.9 to 4.3 3.9, 3.2 to 5.4 < 0.001 3.3, 2.8 to 4.2 0.93
Surgery with cardiopulmonary bypass, n (%) 109 (90.8) 2560 (74.8) < 0.001 110 (91.7) 0.80




< 0.001 128.0, 90.0 to
165.0
0.64
Conventional ultrafiltration rate (mL kg-1 h-1) 93.3, 69.9 to 120.6 96.6, 66.9, 132.3 0.27 98.3, 87.2 to 127.3 0.40
Aristotle scorec 9.0, 7.5 to 10.8 8, 6 to 10 < 0.001 9.0, 7.3 to 10.8 0.99
Surgery with deep hypothermic circulatory arrest, n (%) 19 (15.8) 251 (7.3) < 001 21 (17.5) 0.72
Re-sternotomy, n (%) 19 (15.8) 406 (11.9) 0.19 16 (13.3) 0.59
Requiring re-operation, n (%) 13 (10.8) 177 (5.2) 0.007 16 (13.3) 0.56
Re-operated within 48 hours, n (%) 3 (2.5) 18 (0.5) 0.03 2 (1.7) 0.66
Extracorporeal membrane oxygenation, n (%) 0 23 (0.7) 0
Requirement for delayed sternal closure, n (%) 56 (46.7) 331 (9.7) < 0.001 57 (47.5) 0.85
Delay to sternal closure (days) 3, 2 to 4.2 4, 2 to 6 0.21 4, 3 to 7 0.08
Acute kidney injury requiring renal replacement therapy, n (%) 42 (35.0) 127 (3.7) < 0.001 39 (32.5) 0.58
Requirement for renal replacement therapy on the day of surgery, n
(%)
37 (30.8) 89 (2.6) < 0.001 32 (26.7) 0.36
Duration of renal replacement therapy (days) 2, 1 to 4 3, 2 to 6 0.02 3, 2 to 7 0.09
The propensity score 0.07, 0.02 to 0.31 0.02, 0.01 to 0.03 0.07, 0.02 to 031
The “HFOV group” included all patients switched to high frequency oscillation on the day of surgery, “Overall controls” included all patients ventilated exclusively
conventionally during the study period, and the “CMV group” included the patients ventilated exclusively conventionally in the matched set.
CMV, conventional mechanical ventilation; HFOV, high-frequency oscillatory ventilation.
acalculated before matching, using unpaired tests which compared the HFOV group with overall controls
bcalculated after matching, using paired tests which compared the HFOV group with the CMV group
caccounting for the surgical complexity
Data are shown as medians and inter-quartile ranges, or as numbers and percentages.
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large preoperative left to right shunt [28]. Thus, the use
of HFOV to treat respiratory acidosis in an attempt to
decrease PVR after CPB appears justified. In the present
study, when switching to HFOV, ventilation frequency
was initially set to 8 Hz to promote decarboxylation
and, thus, rapidly increase pH. But the retrospective
design of the present study rendered collection of reli-
able data concerning PVR, Paw and gas exchanges
impossible. Nevertheless, documented pulmonary hyper-
tension was more prevalent in the HFOV group (before
or after transition to HFOV) even after propensity score
matching, showing that the HFOV group was still more
severely ill. Therefore, the shorter durations of mechani-
cal ventilation in the HFOV group suggested a beneficial
effect of HFOV on PVR.
Hemodynamic status
Usually, HFOV involves slightly higher mean Paw values
than CMV, and low cardiac output may occur due to
increased pleural pressure and reduced venous return.
Studies of HFOV in animal models of ARDS have
reported hemodynamic impairment when high airway
pressures were applied [9-11]. Studies of adults [6,12,13]
and infants [29,30] switched from CMV to HFOV have
Table 2 Most prevalent procedures in the matched set, along with their “HFOV indexes”
Most prevalent procedures HFOV group (n = 120) CMV group
(n = 120)
“HFOV index”a
Obstructed TAPVC repair 14 12 0.82
Unrestrictive VSD repair 10 10 0.06
Complete common atrioventricular canal 9 7 0.11
Aortic arch repair 8 7 0.19
Arterial switch operation, VSD repair 6 9 0.08
Truncus arteriosus repair 6 7 0.30
Arterial switch operation 5 8 0.03
Norwood operation 6 6 0.41
Modified Blalock Taussig shunt 5 5 0.09
Tetralogy of Fallot repair 6 4 0.04
Coarctation repair 7 2 0.04
Pulmonary atresia, VSD repair 5 3 0.18
Arterial switch operation, VSD, coarctation repair 3 4 0.18
Bidirectional Glenn 2 4 0.05
Konno Ross procedure 2 4 0.50
Aortic valvuloplasty 3 3 0.10
Other 22 25
CMV, conventional mechanical ventilation; HFOV, high-frequency oscillatory ventilation; TAPVC, total anomalous pulmonary venous connection; VSD, ventricular
septal defect.
aaccounting for the prevalence of HFOV from 1 January 2007 through 30 June 2010
Table 3 Estimates and standard errors for variables included in the propensity score model
Variable Coefficient estimate Standard error P-value
Intercept -2.87 0.58 < 0.001
The “HFOV index”a 3.94 0.48 < 0.001
Age (days) 0.002 0.002 0.19
Weight (kg) -0.37 0.12 0.002
Aristotle scoreb -0.09 0.06 0.10
Surgery with cardiopulmonary bypass 0.87 0.37 0.02
Surgery with deep hypothermic circulatory arrest -0.97 0.33 0.004
Re-operation 0.59 0.34 0.09
Requirement for a delayed sternal closure 0.81 0.29 0.005
Acute kidney injury requiring renal replacement therapy 0.36 0.62 0.56
Requirement for renal replacement therapy on the day of surgery 1.82 0.63 0.004
The propensity score model included only patients operated from 1 January 2007 through 30 June 2010.
HFOV, high-frequency oscillatory ventilation
acalculated as the prevalence of HFOV from 1 January 2007 through 30 June 2010
baccounting for the surgical complexity
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found effects such as increased pulmonary artery occlu-
sion pressure, increased central venous pressure, and
small decreases in cardiac output and stroke volume
index, although it was unclear whether these changes
were clinically relevant.
By contrast, sedation may lead to excessive venous
vasodilatation and impaired venous return following car-
diac surgery, whereas spontaneous breathing maintains a
negative pleural pressure, facilitates venous return and
improves cardiac output. Spontaneous ventilation can be
maintained easily in neonates and small children on
HFOV without increasing the work of breathing [31,32],
thus allowing reduced sedation.
Reliable evaluation of hemodynamic consequences when
changing ventilatory settings is impossible in a retrospec-
tive study. The low mean Paw HFOV strategy employed
in the present study may have allowed the preservation of
hemodynamic stability in these patients. Furthermore, if a
long delay to sternal closure and a long duration of RRT
were considered markers of hemodynamic impairment,
then switching to HFOV may have resulted in hemody-
namic improvement in the present cohort, since both the
delay to sternal closure and the duration of RRT were
slightly reduced in the HFOV group (Table 1).
Limitations
The present study was retrospective and, thus, the
validity of the results must be viewed with caution.
Attempts were made to minimize bias related to
selection of patients switched to HFOV through pro-
pensity score matching. Even though, and despite
adjustment for the year of surgery, the choice of his-
torical controls cannot rule out bias related to
improvements in surgical and medical management of
congenital heart diseases throughout the study period.
Besides, the choice of transition to HFOV was made
by the attending intensivist, and, despite the propen-
sity score methodology employed, we cannot rule out
residual bias related to pre-held beliefs about HFOV’s
performance. Furthermore, analysis of ventilation
Figure 3 Kaplan-Meier plots of the probability of successful weaning over time for each ventilation group. The median length of
mechanical ventilation was 7 days in the high-frequency oscillatory group, inter-quartile range 5 to 11, and 9 days in the conventional
mechanical ventilation group, inter-quartile range 5 to 17, logrank test = 6.18, P = 0.01. CMV, conventional mechanical ventilation; HFOV, high-
frequency oscillatory ventilation.
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parameters and hemodynamic consequences were
lacking. Because of the various intra-cardiac shunting
patterns in the study population, oxygenation indexes
were not analyzed. Future studies should address
these limitations.
Conclusions
When commenced on the day of surgery, HFOV was
associated with a shorter duration of mechanical ventila-
tion and ICU stay in this population of neonates and
infants with respiratory distress following congenital car-
diac surgery. No association was observed between the
use of HFOV and mortality.
Key messages
• HFOV has been shown to be associated with lower
pulmonary vascular resistance after the Fontan
procedure.
• The present study found the use of HFOV to be
associated with shorter length of mechanical
Figure 4 Kaplan-Meier plots of the probability of ICU delivery over time for each ventilation group. The median length of ICU stay was
11 days in the high-frequency oscillatory ventilation group, inter-quartile range 7.2 to 15.7 compared with 14 days in the conventional
mechanical ventilation group, inter-quartile range 9 to 22, logrank test, 9.39, P = 0.002. CMV, conventional mechanical ventilation; HFOV, high-
frequency oscillatory ventilation.
Table 4 Independent predictors of successful weaning from mechanical ventilation and ICU delivery over time
Successful weaning from mechanical ventilation ICU delivery
Variable Adjusted Hazard Ratio 95% CI P-value Adjusted Hazard Ratio 95% CI P-value
HFOV 1.62 1.17 to 2.25 0.004 1.65 1.19 to 2.28 0.002
Delay to sternal closure (days) 0.87 0.82 to 0.93 < 0.001 0.88 0.82 to 0.94 < 0.001
Pulmonary hypertension 0.74 0.54 to 1.02 0.07 0.73 0.53 to 1.01 0.05
Duration of renal replacement therapy (days) 0.95 0.89 to 1.02 0.19 0.94 0.87 to 1.01 0.08
Year of surgery 0.93 0.87 to 0.99 0.03 0.95 0.88 to 1.02 0.16
The propensity score 2.59 1.10 to 6.08 0.03 2.38 0.99 to 5.75 0.05
Adjusted Hazard ratios and 95% CI were estimated using Cox proportional-hazards regression analysis
CI, confidence interval, HFOV, high-frequency oscillatory ventilation
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ventilation and ICU stay in neonates and infants
with respiratory distress following several cardiac
procedures.
• Since our pathophysiological inferences are drawn
from observational results, the beneficial effect of
HFOV needs to be confirmed by interventional
studies.
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